{"certainAgreement":{"otherDetails":"The investigator shall have the right to publish and/or present the clinical data generated from the study provided that such Investigator shall furnish sponsor with a copy of the proposed publication or presentation at least 60 days in advance of submission, delete any confidential information, and delay submission for up to 90 days to permit the preparation and filing of appropriate intellectual property applications.","piSponsorEmployee":false,"restrictionType":"OTHER","restrictiveAgreement":true},"pointOfContact":{"email":"rknight@celgene.com","organization":"Celgene Corporation","phone":"908-673-9749","title":"Robert D. Knight, M.D."}}